| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |